10.11
+0.03(+0.30%)
Currency In NaN
| Previous Close | 10.08 |
| Open | 10.09 |
| Day High | 10.11 |
| Day Low | 10.11 |
| 52-Week High | 10.13 |
| 52-Week Low | 10 |
| Volume | 12,844 |
| Average Volume | 897,835 |
| Market Cap | 206.24M |
| PE | 0 |
| EPS | 0 |
| Moving Average 50 Days | 10.04 |
| Moving Average 200 Days | 10.04 |
| Change | 0.03 |
Drugs Made In America Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing February 25, 2025
GlobeNewswire Inc.
Yesterday at 9:30 PM GMT
Fort Lauderdale, Florida, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition Corp. (Nasdaq: DMAAU) (the “Company”) today announced that, commencing February 25, 2025, holders of the units sold in the Company’s initial public offeri
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option
GlobeNewswire Inc.
Feb 18, 2025 9:45 PM GMT
Fort Lauderdale, Florida, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition Corp. (Nasdaq: DMAAU) (the “Company”) today announced that the underwriter of its previously announced initial public offering fully exercised its option
Drugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
GlobeNewswire Inc.
Jan 29, 2025 9:15 PM GMT
Fort Lauderdale, FL, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition Corp. (Nasdaq: DMAAU), (the “Company”) today announced that it closed its initial public offering of 20,000,000 units at $10.00 per unit. The gross proceeds fr